| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/06/2011 | CN102002105A Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 04/05/2011 | US7919296 Enhancing domains; polymerases; thermal stability |
| 04/05/2011 | CA2455882C Method of protein production in plants |
| 04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 03/31/2011 | WO2011038313A2 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase |
| 03/31/2011 | WO2011038149A2 Methods of treating inflammation |
| 03/31/2011 | WO2011000962A3 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means |
| 03/31/2011 | WO2010120509A3 Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities |
| 03/31/2011 | WO2010118058A3 Polypeptides having cellulase activity |
| 03/31/2011 | US20110077199 Growth hormone polypeptides and methods of making and using same |
| 03/31/2011 | US20110076723 Antibody-peptide fused synergibody |
| 03/31/2011 | CA2773978A1 Methods of treating inflammation |
| 03/30/2011 | EP2301972A1 Method to prepare immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 03/30/2011 | EP2301959A2 Motif-grafted hybrid polypeptides and uses thereof |
| 03/30/2011 | EP2301629A2 Anti-interferon-alpha antibodies |
| 03/30/2011 | EP2301581A1 Production and use of novel peptide-based agents for use with B1-specific antibodies |
| 03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2300501A2 A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 03/30/2011 | EP2121736B1 New anti-malaria vaccine compositions and uses thereof |
| 03/30/2011 | EP1394261B1 Antigens for immunisation |
| 03/30/2011 | CN1956995B Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 03/30/2011 | CN101998965A Immunosuppressive polypeptides and nucleic acid |
| 03/30/2011 | CN101993883A Preparation method of human LIGHT-Fc fusion protein |
| 03/30/2011 | CN101993498A Adenovirus vector avian influenza recombinant vaccine |
| 03/30/2011 | CN101993497A Human proliferation-inducing ligand blocking agent and preparation method and application thereof |
| 03/30/2011 | CN101993496A Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof |
| 03/30/2011 | CN101993495A Protein mixture and preparation method thereof |
| 03/29/2011 | US7915395 Plasmid coding immunogenic fusion protein for use as drug delivery tool; antiproliferative agents; genetic vaccines |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | CA2407514C Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 03/29/2011 | CA2344974C Chimaeric proteins between members of tgf-beta superfamily |
| 03/29/2011 | CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 03/24/2011 | WO2011035082A1 Immunological compositions for hiv |
| 03/24/2011 | WO2011035067A2 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
| 03/24/2011 | WO2011034449A1 Fusion polypeptides and uses thereof |
| 03/24/2011 | US20110071273 Chimeric antigen-specific t cell-activating polypeptides |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110070658 Systems and methods for determining the percentage of glycated hemoglobin |
| 03/24/2011 | US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 03/24/2011 | US20110070165 Multivalent constructs for therapeutic and diagnostic applications |
| 03/24/2011 | CA2780512A1 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
| 03/24/2011 | CA2774333A1 Fusion polypeptides and uses thereof |
| 03/24/2011 | CA2774260A1 Class i anti-cea antibodies and uses thereof |
| 03/24/2011 | CA2774154A1 Immunological compositions for hiv |
| 03/23/2011 | EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 03/23/2011 | EP2298802A1 T1R3 taste receptors and genes encoding same |
| 03/23/2011 | EP2298796A2 Staphylococcus aureus proteins and nucleic acids |
| 03/23/2011 | EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298331A2 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 03/23/2011 | EP2297346A2 METHODS AND REAGENTS FOR DETECTING CpG METHYLATION WITH A METHYL CpG BINDING PROTEIN (MBP) |
| 03/23/2011 | EP1285004B1 method of producing synthetic peptides |
| 03/23/2011 | CN101988058A Gene expression composition, PRRS (Porcine Reproductive and Respiratory Syndrome) oral vaccine and preparation methods thereof |
| 03/23/2011 | CN101987873A P53 fusion protein and application thereof |
| 03/23/2011 | CN101328221B Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 03/23/2011 | CN101070350B Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910707 Anti-interferon-α antibodies |
| 03/22/2011 | US7910364 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/22/2011 | US7910350 Adaptor-directed helper systems |
| 03/22/2011 | CA2390166C Hedgehog fusion proteins and uses |
| 03/22/2011 | CA2240409C Mammalian cx3c chemokine genes |
| 03/22/2011 | CA2223013C Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 03/17/2011 | WO2011031477A2 Nucleolin-binding peptides, nucleolin-binding lytic peptides, fusion constructs and methods of making and using same |
| 03/17/2011 | CA2771863A1 Compositions that induce t cell help |
| 03/16/2011 | EP2295596A1 A method and kit for purification of recombinant proteins using a self-cleaving ptotein intein |
| 03/16/2011 | EP2295565A1 Polynucleotide for releasing recombinant protein to the outside of eukaryotic cell |
| 03/16/2011 | EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295082A1 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
| 03/16/2011 | EP2294202A1 Soluble recombinant influenza antigens |
| 03/16/2011 | EP2294090A2 Non-hemolytic clya for excretion of proteins |
| 03/16/2011 | EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 03/16/2011 | EP2294081A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 03/16/2011 | EP2293811A1 Derivatised hybrid peptides of amylin and salmon calcitonin |
| 03/16/2011 | EP2173890B1 Biological active proteins having increased in vivo and/or vitro stability |
| 03/16/2011 | CN101985478A Fusion protein and application thereof to ischemic brain stroke |
| 03/16/2011 | CN101985477A Fusion protein for evaluating HCV NS3/4A serine proteinase inhibitor and application thereof |
| 03/16/2011 | CN101362796B B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 03/16/2011 | CN101186639B Fusion protein and its coding gene and use |
| 03/15/2011 | US7906628 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis |
| 03/15/2011 | CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
| 03/10/2011 | WO2011029008A2 Synbodies to akt1 |
| 03/10/2011 | WO2011028344A2 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027839A1 Cholesterol-efflux peptide |
| 03/10/2011 | WO2011026447A1 New antibiotic containing simulacrum antibody, preparation method and application thereof |
| 03/10/2011 | WO2010148511A8 Chimeric influenza virus-like particles comprising hemagglutinin |
| 03/10/2011 | WO2010132092A3 Cytidine deaminase fusions and related methods |
| 03/10/2011 | WO2010124296A3 Compositions containing hc•ha complex and methods of use thereof |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/09/2011 | EP2292658A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 |